))
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
…
continue reading
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
In this episode, we explore lamotrigine's cardiac side effects, focusing on QTc prolongation and QRS widening. How concerned should psychiatrists be about the FDA warning regarding lamotrigine's cardiac effects? We examine the evidence behind these concerns and discuss practical implications for clinical practice. Faculty: Scott Beach, M.D. Host: R…
…
continue reading
1
Rethinking Falls: Are Sleep Medications Really to Blame?
12:09
12:09
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:09
In this episode, we examine a groundbreaking Danish study that challenges the conventional belief that sedative medications increase fall risk in older adults. Could untreated insomnia, rather than the medications used to treat it, be the real culprit behind falls in elderly patients? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more…
…
continue reading
1
Navigating Lamotrigine's Side Effects
10:42
10:42
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:42
In this episode, we explore lamotrigine's side effects and special considerations, particularly focusing on identifying dangerous skin reactions, pregnancy considerations, and overdose risks. Did you know that Asian populations may require special genetic screening before starting lamotrigine due to increased skin reaction risks? Faculty: Scott Bea…
…
continue reading
In this episode, we explore the efficacy and safety of iloperidone in treating bipolar disorder, examining new phase 3 trial data that reveals both promising results for mania symptoms and important considerations about side effects. Can this antipsychotic's favorable EPS profile outweigh its metabolic risks? Faculty: Paul Zarkowski, M.D. Host: Ric…
…
continue reading
In this episode, we explore the vital aspects of prescribing lamotrigine, from its mechanisms to titration schedules. Did you know that birth control pills can cut lamotrigine levels in half within just one week? Understanding these interactions is crucial for safe and effective treatment. Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn…
…
continue reading
1
Beyond Benzos: New Frontiers in Agitation Management
10:19
10:19
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:19
In this episode, we explore the pharmacological management of agitation in emergency settings, focusing on benzodiazepines and the novel medication dexmedetomidine. Did you know there's now a sublingual option that works through an entirely different mechanism than traditional anti-agitation medications? Faculty: Scott Zeller, M.D. Host: Richard Se…
…
continue reading
1
KarXT: A New Dawn in Antipsychotic Treatment
11:40
11:40
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:40
In this episode, we explore KarXT, a groundbreaking experimental antipsychotic that works through the cholinergic system rather than dopamine pathways. Could this novel approach revolutionize schizophrenia treatment by offering similar efficacy to current antipsychotics but without the motor side effects? Faculty: Oliver Freudenreich, M.D. Host: Ri…
…
continue reading
1
Rethinking Agitation Management: From Force to Partnership
10:50
10:50
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:50
In this episode, we explore evidence-based pharmacologic strategies for managing acute agitation in emergency settings, challenging the stigmatizing concept of “chemical restraints” and providing practical approaches to achieve optimal patient outcomes. Did you know that many agitated patients can actively participate in medication decisions, even …
…
continue reading
1
COVID Brain Fog: Repurposing Famotidine
10:56
10:56
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
10:56
In this episode, we explore how famotidine, a common heartburn medication, might help treat post-COVID brain fog. New research suggests this H2 blocker could improve cognitive function in recovering patients. But how does a stomach acid reducer potentially clear mental haziness? Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about…
…
continue reading
1
Beyond Restraints: De-Escalation in Behavioral Emergencies
11:45
11:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:45
In this episode, we explore nonpharmacologic strategies for managing agitated patients, focusing on verbal de-escalation techniques. Did you know that using physical restraints adds an average of four hours to an emergency department stay? Dr. Scott Zeller shares evidence-based approaches to transform crisis intervention in emergency settings. Facu…
…
continue reading
1
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
13:34
13:34
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
13:34
In this episode, we explore the RADAR trial's findings on antipsychotic dose reduction in schizophrenia. Can patients with chronic schizophrenia safely reduce or discontinue their antipsychotic medications without increasing relapse risk? The trial's results challenge common assumptions about medication reduction and provide crucial guidance for cl…
…
continue reading
1
Unraveling Agitation: Mania vs. Substance Use
11:06
11:06
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:06
In this episode, we explore the challenges of diagnosing and managing agitation in emergency settings, focusing on mood disorders and substance use. Dr. Scott Zeller shares insights on differentiating acute mania from substance-induced psychosis. How can clinicians navigate the complex interplay between psychiatric symptoms and substance effects in…
…
continue reading
1
Pushing the Boundaries: Exploring High-Dose Antipsychotics
11:00
11:00
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
11:00
In this episode, we explore the use of high-dose olanzapine as a potential alternative to clozapine for treatment-resistant schizophrenia. We discuss a systematic review that examines the efficacy and safety of olanzapine doses above the FDA-approved maximum. Could high-dose olanzapine be a viable option when patients refuse clozapine? Faculty: Oli…
…
continue reading
